Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction

Abstract Background The efficacy and safety of low-pressure balloon pre-dilatation before intracoronary pro-urokinase (pro-UK) in preventing no-reflow during percutaneous coronary intervention (PCI) remains unknown. This study aimed to evaluate the clinical outcomes of intracoronary pro-UK combined...

Full description

Bibliographic Details
Main Authors: Shicheng Yu, Haoxuan Jia, Shengkai Ding, Mengda Zhang, Fengyun Li, Pan Xu, Yuan Tian, Lingling Ma, Lijie Gong, Jun Feng, Zhaojin Sun, Fudong Qian, Hui Li
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:https://doi.org/10.1186/s13019-024-02699-7
_version_ 1797219589163057152
author Shicheng Yu
Haoxuan Jia
Shengkai Ding
Mengda Zhang
Fengyun Li
Pan Xu
Yuan Tian
Lingling Ma
Lijie Gong
Jun Feng
Zhaojin Sun
Fudong Qian
Hui Li
author_facet Shicheng Yu
Haoxuan Jia
Shengkai Ding
Mengda Zhang
Fengyun Li
Pan Xu
Yuan Tian
Lingling Ma
Lijie Gong
Jun Feng
Zhaojin Sun
Fudong Qian
Hui Li
author_sort Shicheng Yu
collection DOAJ
description Abstract Background The efficacy and safety of low-pressure balloon pre-dilatation before intracoronary pro-urokinase (pro-UK) in preventing no-reflow during percutaneous coronary intervention (PCI) remains unknown. This study aimed to evaluate the clinical outcomes of intracoronary pro-UK combined with low-pressure balloon pre-dilatation in patients with anterior ST-segment-elevation myocardial infarction (STEMI). Methods This was a randomized, single-blind, investigator-initiated trial that included 179 patients diagnosed with acute anterior STEMI. All patients were eligible for PCI and were randomized into two groups: intracoronary pro-UK combined with (ICPpD group, n = 90) or without (ICP group, n = 89) low-pressure balloon pre-dilatation. The main efficacy endpoint was complete epicardial and myocardial reperfusion. The safety endpoints were major adverse cardiovascular events (MACEs), which were analyzed at 12 months follow-up. Results Patients in the ICPpD group presented significantly higher TIMI myocardial perfusion grade 3 (TMPG3) compared to those in the ICP group (77.78% versus 68.54%, P = 0.013), and STR ≥ 70% after PCI 30 min (34.44% versus 26.97%, P = 0.047) or after PCI 90 min (40.0% versus 31.46%, P = 0.044). MACEs occurred in 23 patients (25.56%) in the ICPpD group and in 32 patients (35.96%) in the ICP group. There was no difference in hemorrhagic complications during hospitalization between the groups. Conclusion Patients with acute anterior STEMI presented more complete epicardial and myocardial reperfusion with adjunctive low-pressure balloon pre-dilatation before intracoronary pro-UK during PCI. Trial registration 2019xkj213.
first_indexed 2024-04-24T12:36:03Z
format Article
id doaj.art-4e96beffaf724de6b4776c74a8c5db46
institution Directory Open Access Journal
issn 1749-8090
language English
last_indexed 2024-04-24T12:36:03Z
publishDate 2024-04-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj.art-4e96beffaf724de6b4776c74a8c5db462024-04-07T11:30:15ZengBMCJournal of Cardiothoracic Surgery1749-80902024-04-0119111310.1186/s13019-024-02699-7Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarctionShicheng Yu0Haoxuan Jia1Shengkai Ding2Mengda Zhang3Fengyun Li4Pan Xu5Yuan Tian6Lingling Ma7Lijie Gong8Jun Feng9Zhaojin Sun10Fudong Qian11Hui Li12Department of Cardiology, Lu’an Hospital of Anhui Medical UniversityGraduate School of Bengbu Medical CollegeDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityDepartment of Cardiology, Lu’an Hospital of Anhui Medical UniversityAbstract Background The efficacy and safety of low-pressure balloon pre-dilatation before intracoronary pro-urokinase (pro-UK) in preventing no-reflow during percutaneous coronary intervention (PCI) remains unknown. This study aimed to evaluate the clinical outcomes of intracoronary pro-UK combined with low-pressure balloon pre-dilatation in patients with anterior ST-segment-elevation myocardial infarction (STEMI). Methods This was a randomized, single-blind, investigator-initiated trial that included 179 patients diagnosed with acute anterior STEMI. All patients were eligible for PCI and were randomized into two groups: intracoronary pro-UK combined with (ICPpD group, n = 90) or without (ICP group, n = 89) low-pressure balloon pre-dilatation. The main efficacy endpoint was complete epicardial and myocardial reperfusion. The safety endpoints were major adverse cardiovascular events (MACEs), which were analyzed at 12 months follow-up. Results Patients in the ICPpD group presented significantly higher TIMI myocardial perfusion grade 3 (TMPG3) compared to those in the ICP group (77.78% versus 68.54%, P = 0.013), and STR ≥ 70% after PCI 30 min (34.44% versus 26.97%, P = 0.047) or after PCI 90 min (40.0% versus 31.46%, P = 0.044). MACEs occurred in 23 patients (25.56%) in the ICPpD group and in 32 patients (35.96%) in the ICP group. There was no difference in hemorrhagic complications during hospitalization between the groups. Conclusion Patients with acute anterior STEMI presented more complete epicardial and myocardial reperfusion with adjunctive low-pressure balloon pre-dilatation before intracoronary pro-UK during PCI. Trial registration 2019xkj213.https://doi.org/10.1186/s13019-024-02699-7STEMIPCIPro-urokinaseEfficacySafety
spellingShingle Shicheng Yu
Haoxuan Jia
Shengkai Ding
Mengda Zhang
Fengyun Li
Pan Xu
Yuan Tian
Lingling Ma
Lijie Gong
Jun Feng
Zhaojin Sun
Fudong Qian
Hui Li
Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction
Journal of Cardiothoracic Surgery
STEMI
PCI
Pro-urokinase
Efficacy
Safety
title Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction
title_full Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction
title_fullStr Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction
title_full_unstemmed Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction
title_short Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction
title_sort efficacy and safety of intracoronary pro urokinase combined with low pressure balloon pre dilatation during percutaneous coronary intervention in patients with anterior st segment elevation myocardial infarction
topic STEMI
PCI
Pro-urokinase
Efficacy
Safety
url https://doi.org/10.1186/s13019-024-02699-7
work_keys_str_mv AT shichengyu efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT haoxuanjia efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT shengkaiding efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT mengdazhang efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT fengyunli efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT panxu efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT yuantian efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT linglingma efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT lijiegong efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT junfeng efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT zhaojinsun efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT fudongqian efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction
AT huili efficacyandsafetyofintracoronaryprourokinasecombinedwithlowpressureballoonpredilatationduringpercutaneouscoronaryinterventioninpatientswithanteriorstsegmentelevationmyocardialinfarction